Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-09

Clinical Trial Update: Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ceftaroline fosamil versus vancomycin plus aztreonam in complicated skin and soft tissue infections has completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aztreonam (aztreonam)
  • Vancomycin (vancomycin)
  • ceftaroline fosamil (ceftaroline fosamil)

Snippet

Sponsor: Pfizer | Conditions: Complicated Skin and Soft Tissue Infection | Phase 3 | Status: COMPLETED | Results posted: 2015-11-09